NEO
Neogenomics Inc.

2,859
Mkt Cap
$1.28B
Volume
1.85M
52W High
$13.74
52W Low
$4.72
PE Ratio
-11.72
NEO Fundamentals
Price
$9.89
Prev Close
$10.01
Open
$10.03
50D MA
$12.04
Beta
1.42
Avg. Volume
2.03M
EPS (Annual)
-$0.8433
P/B
1.52
Rev/Employee
$290,932.80
$1,756.31
Loading...
Loading...
News
all
press releases
NeoGenomics, Inc. $NEO Shares Bought by White Pine Capital LLC
White Pine Capital LLC lifted its position in NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 394.3% during the 3rd quarter, according to the company in its most recent filing with the Securities and...
MarketBeat·4h ago
News Placeholder
More News
News Placeholder
NeoGenomics, Inc. $NEO Stock Holdings Lifted by Aberdeen Group plc
Aberdeen Group plc raised its position in shares of NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 91.8% in the third quarter, according to its most recent 13F filing with the Securities and...
MarketBeat·10h ago
News Placeholder
After Plunging 22.8% in 4 Weeks, Here's Why the Trend Might Reverse for NeoGenomics (NEO)
NeoGenomics (NEO) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Zacks·1d ago
News Placeholder
NeoGenomics (NASDAQ:NEO) Trading Down 8.9% - Should You Sell?
NeoGenomics (NASDAQ:NEO) Trading Down 8.9% - Here's Why...
MarketBeat·3d ago
News Placeholder
Needham & Company LLC Forecasts Strong Price Appreciation for NeoGenomics (NASDAQ:NEO) Stock
Needham & Company LLC boosted their price target on shares of NeoGenomics from $14.00 to $15.00 and gave the company a "buy" rating in a report on Tuesday...
MarketBeat·3d ago
News Placeholder
NeoGenomics to Participate in Upcoming Investor Conferences
NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the Company will participate in the following investor conferences...
Business Wire·3d ago
News Placeholder
NeoGenomics (NASDAQ:NEO) Shares Gap Down - Time to Sell?
NeoGenomics (NASDAQ:NEO) Shares Gap Down - Here's Why...
MarketBeat·4d ago
News Placeholder
NeoGenomics Q4 Earnings Call Highlights
NeoGenomics (NASDAQ:NEO) reported fourth-quarter and full-year 2025 results that management said reflected improving execution through the year, highlighted by record quarterly revenue, continued...
MarketBeat·4d ago
News Placeholder
NeoGenomics (NEO) Q4 2025 Earnings Call Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets·4d ago
News Placeholder
NeoGenomics (NEO) Q4 Earnings and Revenues Surpass Estimates
NeoGenomics (NEO) delivered earnings and revenue surprises of +57.90% and +0.90%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·4d ago
<
1
2
...
>

Latest NEO News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.